ClinicalTrials.Veeva

Menu
P

Pulmonary Associates of Richmond | West Broad

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Treprostinil
ACT-541468
Remimazolam
CPFE
Mannitol
Daridorexant
Tetomilast
Deupirfenidone
Nitric Oxide
Seralutinib

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 22 total trials

A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

A randomized, double-blind, placebo-controlled dose escalation study to assess the safety and efficacy of pulsed, inhaled nitric oxide (iNO) in subje...

Active, not recruiting
Pulmonary Fibrosis
Pulmonary Hypertension
Combination Product: Placebo
Combination Product: INOpulse®

The primary objective of the study is to determine the effect of seralutinib on improving exercise capacity in subjects with WHO Group 1 PAH who are...

Enrolling
Pulmonary Arterial Hypertension
Drug: Placebo
Drug: Seralutinib

Study RIN-PF-302 is designed to evaluate the long-term safety and tolerability of inhaled treprostinil in subjects with idiopathic pulmonary fibrosis.

Invitation-only
Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease
Device: Treprostinil Ultrasonic Nebulizer
Drug: Inhaled Treprostinil

This study a randomized, double-blind, four arm study to evaluate the safety and efficacy of LYT-100 compared to pirfenidone or placebo in adults wit...

Active, not recruiting
Idiopathic Pulmonary Fibrosis
Drug: Placebo
Drug: Deupirfenidone

Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FV...

Enrolling
Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease
Drug: Inhaled Treprostinil
Drug: Placebo

Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a...

Enrolling
Progressive Pulmonary Fibrosis
Interstitial Lung Disease
Device: Treprostinil Ultrasonic Nebulizer
Drug: Placebo

Trial sponsors

United Therapeutics logo
B
B
Boston Scientific logo
Exact Sciences Corporation logo
G
Idorsia Pharmaceuticals logo
Janssen (J&J Innovative Medicine) logo
Otsuka logo
P

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems